Actively Recruiting
Study on Hyperviscosity Syndrome Diagnosis in Adults with Waldenstrom Macroglobulinemia
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-05-29
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Waldenstrm Macroglobulinemia WM is a condition marked by abnormal bone marrow cell growth and the presence of a specific antibody called immunoglobulin M IgM in the blood. The study focuses on hyperviscosity syndrome HVS, a common complication in WM caused by high levels or certain properties of IgM, leading to symptoms like bleeding and fatigue. Researchers aim to develop a clear diagnostic system for HVS based on both objective signs such as eye exam findings and subjective symptoms including fatigue and related health problems. The research involves evaluating patients with WM who may need treatment, including those with a high serum monoclonal component or those undergoing hyperviscosity assessment. Participants will undergo fundoscopic imaging reviewed centrally, blood collection for various analyses including expression studies, and bone marrow sampling for molecular study. Patients are grouped based on the confirmation or absence of HVS, and the study is non-randomized without blinding. During the three-year study, participants will complete questionnaires and undergo eye examinations to correlate symptoms and findings with the presence of HVS. Blood and bone marrow samples will be collected to better understand the disease characteristics. The study is designed to monitor these assessments over time to identify reliable ways to detect HVS and guide treatment decisions. Participants must consent to the study and will be followed according to the schedule outlined by the research team.
CONDITIONS
Brief Title
Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia
Research Team
M
Magalie JORIS, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here